Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 119,500
-1,600 (-1.32%)
At close: Jun 8, 2026
Daewoong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,393,409 | 1,982,530 | 1,454,393 | 1,343,932 | 1,754,469 | 1,638,243 | |
Market Cap Growth | -13.93% | 36.31% | 8.22% | -23.40% | 7.09% | -7.75% |
Enterprise Value | 2,254,027 | 2,726,264 | 2,099,040 | 1,735,899 | 2,148,696 | 2,022,062 |
Last Close Price | 121100.00 | 172300.00 | 125964.64 | 115832.21 | 156366.58 | 145448.14 |
PE Ratio | 6.97 | 10.12 | 58.80 | 11.04 | 41.54 | 66.85 |
Forward PE | 7.63 | 11.76 | 14.39 | 14.77 | 41.35 | 41.35 |
PS Ratio | 0.88 | 1.26 | 1.02 | 0.98 | 1.37 | 1.42 |
PB Ratio | 1.21 | 1.75 | 1.51 | 1.43 | 2.37 | 2.35 |
P/TBV Ratio | 2.17 | 2.29 | 2.24 | 2.15 | 3.79 | 3.83 |
P/FCF Ratio | - | - | - | 50.39 | 33.11 | 150.21 |
P/OCF Ratio | 8.53 | 13.29 | 28.25 | 9.88 | 14.84 | 40.96 |
PEG Ratio | 1.66 | 0.19 | 1.07 | 0.78 | 0.24 | 0.24 |
EV/Sales Ratio | 1.42 | 1.74 | 1.48 | 1.26 | 1.68 | 1.75 |
EV/EBITDA Ratio | 8.23 | 11.06 | 10.81 | 10.53 | 15.86 | 15.60 |
EV/EBIT Ratio | 10.30 | 13.95 | 14.45 | 14.33 | 22.43 | 22.79 |
EV/FCF Ratio | -27.39 | - | - | 65.09 | 40.55 | 185.40 |
Debt / Equity Ratio | 0.78 | 0.73 | 0.68 | 0.47 | 0.60 | 0.64 |
Debt / EBITDA Ratio | 3.85 | 3.36 | 3.34 | 2.68 | 3.30 | 3.44 |
Debt / FCF Ratio | - | - | - | 16.55 | 8.43 | 40.87 |
Net Debt / Equity Ratio | 0.64 | 0.58 | 0.55 | 0.32 | 0.41 | 0.39 |
Net Debt / EBITDA Ratio | 3.13 | 2.66 | 2.74 | 1.84 | 2.26 | 2.10 |
Net Debt / FCF Ratio | -8.90 | -15.51 | -5.14 | 11.38 | 5.78 | 24.94 |
Asset Turnover | 0.72 | 0.72 | 0.76 | 0.83 | 0.86 | 0.83 |
Inventory Turnover | 2.62 | 2.64 | 2.77 | 3.06 | 3.39 | 3.54 |
Quick Ratio | 0.59 | 0.66 | 0.55 | 0.47 | 0.68 | 0.72 |
Current Ratio | 1.12 | 1.24 | 1.03 | 0.86 | 1.16 | 1.13 |
Return on Equity (ROE) | 19.07% | 18.40% | 2.45% | 14.27% | 5.44% | 4.32% |
Return on Assets (ROA) | 5.04% | 5.63% | 4.84% | 4.54% | 4.03% | 3.99% |
Return on Invested Capital (ROIC) | 9.62% | 11.90% | 4.38% | 10.40% | 9.50% | 9.18% |
Return on Capital Employed (ROCE) | 10.00% | 11.00% | 10.50% | 11.00% | 8.80% | 9.30% |
Earnings Yield | 14.34% | 9.88% | 1.70% | 9.06% | 2.41% | 1.50% |
FCF Yield | -5.91% | -2.14% | -7.13% | 1.98% | 3.02% | 0.67% |
Dividend Yield | 0.50% | 0.35% | - | - | - | - |
Payout Ratio | 4.53% | 4.12% | 31.30% | 5.98% | 19.10% | 26.35% |
Buyback Yield / Dilution | 0.03% | - | -0.71% | -3.21% | -0.59% | -3.21% |
Total Shareholder Return | 0.52% | 0.35% | -0.71% | -3.21% | -0.59% | -3.21% |